| Journal: | Revista da Sociedade Brasileira de Medicina Tropical |
| Database: | PERIÓDICA |
| System number: | 000282257 |
| ISSN: | 0037-8682 |
| Authors: | Goulart, Isabela Maria Bernades1 Arbex, Guilherme Leonel Carneiro, Marcus Hubaide Rodrigues, Mariana Scalia Gadia, Rafael |
| Institutions: | 1Universidade Federal de Uberlandia, Faculdade de Medicina, Uberlandia, Minas Gerais. Brasil |
| Year: | 2002 |
| Season: | Sep-Oct |
| Volumen: | 35 |
| Number: | 5 |
| Pages: | 453-460 |
| Country: | Brasil |
| Language: | Portugués |
| Document type: | Artículo |
| Approach: | Descriptivo |
| English abstract | The introduction of multidrug therapy (WHO/MDT) - composed by the drugs dapsone, clofazimine and rifampicin has enabled the cure of Hansen's disease, however, the adverse effects of these drugs were not given priority by the health team. Aiming to determine MDT's adverse effects' magnitude and relate them to the non-adhesion of patients to the treatment, a study of 187 charts of patients treated with MDT from January of 1995 to May 2000, was carried out at a Health Center of the Federal University of Uberlândia. Side effects were recorded in 71 patients' charts. Among the 113 side effects found, 80 (70.7%) were related to dapsone, 7 (6.2%) were caused by rifampicin and 26 (20.5%) were attributed to clofazimine. These effects induced 28 (14.9%), patients to change the therapeutic scheme, representing 39.4% from the 71 patients with adverse effects. Throughout this study, the importance is discussed of considering MDT's adverse effects when training the health team to heighten the patient's adhesion to the treatment and thereby collaborating to eliminate Hansen's disease as a public health problem |
| Portuguese abstract | A implementação da poliquimioterapia (PQT/OMS) - composta pelas drogas dapsona, clofazimina e rifampicina - possibilitou a cura da hanseníase, porém não foram priorizados o manejo dos efeitos adversos pelas equipes de saúde. Objetivando determinar a magnitude dos efeitos adversos da poliquimioterapia para hanseníase e relacioná-los como possível causa de não adesividade do paciente ao tratamento, revisou-se prontuários de 187 pacientes tratados com PQT, de 1995 a 2000, no Centro de Saúde Escola (CSE) ¾ UFU, com registro de efeitos colaterais em 71 pacientes (37,9%). Dentre os 113 efeitos adversos, 80 (70,7%) relacionaram-se à dapsona, 7 (6,2%) à rifampicina, 26 (20,5%) à clofazimina. Esses efeitos levaram à mudança de esquema terapêutico em 28 (14,9%) dos 187 pacientes ou 39,4% dos 71 com efeitos adversos. Discute-se a importância de considerar os efeitos adversos da PQT na capacitação das equipes de saúde para maior adesão do paciente ao tratamento, colaborando para eliminar a hanseníase como problema de saúde pública |
| Disciplines: | Medicina |
| Keyword: | Farmacología, Salud pública, Terapéutica y rehabilitación, Lepra, Reacciones adversas, Poliquimioterapia, Brasil, Medicamentos |
| Keyword: | Medicine, Pharmacology, Public health, Therapeutics and rehabilitation, Leprosy, Adverse effects, Polychemotherapy, Brazil, Drugs |
| Full text: | Texto completo (Ver HTML) |
